An Advisory Committee to the FDA recently unanimously agreed (11 to 0) that GlaxoSmithKline's Advair DiskusĀ® 500/50 (fluticasone propionate and salmeterol ...
An Advisory Committee to the US Food and Drug Administration (FDA) today unanimously agreed (11 to 0) that GlaxoSmithKline's Advair DiskusĀ® 500/50 ...
In 2005, the Food and Drug Administration requested the manufacturers of Advair diskus, Foradil Aerolizer and Servent diskus update their product labels ...
LONDON: GlaxoSmithKline PLC said Wednesday it received approval for its Seretide/Advair Diskus and Arixtra bronchial asthma treatment in Japan. ...
Seretide/Advair will be branded Advair Diskus, and has been approved for adult patients with bronchial asthma. Glaxo said it will be the only combination ...
LONDON (Dow Jones)--GlaxoSmithKline Wednesday announced that it has received approval for Seretide/Advair Diskus and Arixtra from the Ministry of Health, ...
GlaxoSmithKline has received approval in Japan for its key respiratory product Seretide/Advair Diskus and its anti-thrombotic Arixtra, a move which the ...
GlaxoSmithKline (GSK) today announced that it has received approval for Seretide/Advair Diskus (salmeterol and fluticasone proprionate combination) and ...
... view that the highest dose of its asthma blockbuster Advair Diskus can increase survival rates for patients with chronic obstructive pulmonary disease. ...
(May 1, 2007)-- An Advisory Committee to the US Food and Drug Administration (FDA) unanimously agreed (11 to 0) that GlaxoSmithKline's Advair Diskus(R) ...